Kaken Pharmaceutical Market Cap

Kaken Pharmaceutical has a market cap or net worth of 153.75 billion as of April 28, 2026. Its market cap has decreased by -9.69% in one year.

Market Cap

153.75B

Enterprise Value

111.76B

Revenue

75.66B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,060.00

Market Cap Chart

Since March 26, 1993, Kaken Pharmaceutical's market cap has increased from 118.38B to 153.75B, an increase of 29.88%. That is a compound annual growth rate of 0.79%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	153.75B	1.12%
Dec 30, 2025	152.04B	-11.05%
Dec 30, 2024	170.93B	34.53%
Dec 29, 2023	127.05B	-12.84%
Dec 30, 2022	145.77B	-8.45%
Dec 30, 2021	159.22B	3.78%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Kissei Pharmaceutical	188.40B
Mochida Pharmaceutical	118.76B
Towa Pharmaceutical	201.10B
Sawai Group Holdings	242.35B
Zeria Pharmaceutical	94.95B
KYORIN Pharmaceutical	89.50B
Tsumura & Co.	275.82B
ASKA Pharmaceutical Holdings	84.76B

Market Cap Rankings